Tisotumab vedotin (anti-Tissue Factor) is an antibody-drug conjugate (ADC) targeting tissue factor (TF). Tisotumab vedotin (anti-Tissue Factor) consists of a fully human monoclonal antibody to tissue factor (TF-011) conjugated to Monomethyl Auristatin E (MMAE). Tisotumab vedotin (anti-Tissue Factor) has good antitumor activity and can be used in the research of advanced or metastatic solid tumors. Purity
≥90% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
规格
产品名称
Tisotumab vedotin (anti-Tissue Factor), 凝血因子 III 抗体;组织因子
别名
Tisotumab vedotin(抗组织因子)
英文别名
CD142 antibody|CD142 antigen antibody|Coagulation factor III (thromboplastin tissue factor) antibody|Coagulation factor III antibody|F3 antibody|FLJ17960 antibody|TF antibody|TFA antibody|Thromboplastin antibody|Tissue factor antibody|CD142 antigen|CD142|coagulation factor III (thromboplastin, tissue factor)|Coagulation Factor III|F3|TF|TFA|Thromboplastin|Tissue Factor
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Tisotumab vedotin (anti-Tissue Factor) (Ab175681) - Flow Cytometry Flow Cytometry analysis of A431 cells labelling Tissue Factor (red) with Tisotumab vedotin (anti-Tissue Factor) (Ab175681). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Tisotumab vedotin (anti-Tissue Factor) (Ab175681) - SEC The purity of Tisotumab vedotin (anti-Tissue Factor) (Ab175681) is more than 95% verified by HPLC.